H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 17.6% of adults in Memphis have diagnosed diabetes — 5.6 points above the U.S. 12% figure. Census population 633,104. Tennessee Medicare wound biologics: Palmetto GBA (JJ). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Memphis clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Memphis storefront.
Growth Factor Therapy for Tissue Repair in Memphis, TN for clinics & physicians. Growth factor therapy pro… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of growth factor therapy in Memphis: (1) CDC PLACES (2023, crude) estimates 17.6% of adults in Memphis have diagnosed diabetes — 5.6 points above the U.S. 12% figure. (2) Tennessee Part B wound biologics are reviewed by Palmetto GBA under JJ, shared with AL, GA. We help with the second file. We do not pretend to be a Memphis storefront.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)Tennessee shares JJ with AL, GA. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 17.6% of adults in Memphis have diagnosed diabetes — 5.6 points above the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Memphis trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 17.6% of adults in Memphis have diagnosed diabetes — 5.6 points above the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 17.6% of adults — 5.6 points above the U.S. 12% figure. Obesity is 42.1%; arthritis is 27.3%. That is place-level BRFSS modeling, not a clinic census and not a Memphis trial.
City-proper counts are unambiguous and match the URL slug. MSA figures change with OMB delineations and would be easy to get wrong. We would rather under-claim than invent a metro number.
It is the Census city-proper count — useful as scale for a city of 500k–1M. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
Bring specialty, monthly joint / regenerative volume, and whether you bill JJ FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 17.6% diabetes and 27.3% arthritis for Memphis — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Memphis, TN.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Memphis is JJ geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Memphis — 5.6 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Tennessee Part B wound biologics follow this contractor (siblings: AL, GA). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Memphis. Useful for joint-program math; still needs a diagnosis and privileging.
No Memphis storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.